☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ADHD
ADHD Treatment Options: Therapy, Medication, and More
May 16, 2024
Supernus' Qelbree (SPN-812) Receives the US FDA's Approval for the Treatment of ADHD
April 2, 2021
Corium's Azstarys (serdexmethylphenidate and dexmethylphenidate) Receives the US FDA's Approval for ADHD in Patients Aged 6 Years...
March 3, 2021
Akili's EndeavorRx Receives the US FDA's Approval as the First Game-Based Digital Therapeutic to Improve Attention Function in Chi...
June 16, 2020
Shionogi Signs Development & Commercialization Agreement with Akili for its AKL-T01 and AKL-T02 for ADHD & ASD
March 8, 2019
Eurofarma Signs an Exclusive Development and Commercialization Agreement with NLS-1 Pharma for its Nalazol Therapy
February 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.